39 In this study, NT-RFA showed a trend toward improved RFS (HR 0.81, 95% CI 0.57 to 1.15).
← all excerpts
Efficacy and safety of multiple treatments for small hepatocellular carcinoma: an updated systematic review and component network meta analysis.
1
—
—